| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/06/2008 | CN100366292C Recombinant porcine adenovirus vector |
| 02/06/2008 | CN100366291C O, A type bivalent inactivated vaccine for foot-and-mouth disease of ruminant as cattle and sheep |
| 02/06/2008 | CN100366290C Coccidial vaccine and methods of making and using same |
| 02/05/2008 | US7326774 Monoclonal antibody and nematode larval antigens |
| 02/05/2008 | US7326773 PRO6493 antibodies |
| 02/05/2008 | US7326769 Subjecting an extract of a group 1, 2, 3, 10, and/or 13 Phleum pretense to hydrophobic interaction chromatography, followed by gel filtration and optionally followed by cation exchanger chromatography; facilitate improved diagnosis of pollen allergies |
| 02/05/2008 | US7326768 Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
| 02/05/2008 | US7326682 Conotoxin peptides |
| 02/05/2008 | US7326574 Immunogenic peptide sequences; antibodies directed against particular amino acid regions of Hsp70B' |
| 02/05/2008 | US7326569 Hybridoma cell lines producing chimeric antibody having the variable regions of the antibody produced by a cell line with ATCC (TM) deposit number HB11364, HB11637, or HB11363 |
| 02/05/2008 | US7326568 Recombinant expression of heterologous nucleic acids in protozoa |
| 02/05/2008 | US7326555 Using domiphen bromide to selectively precipitate viral particles from DNA mixtures; ion echange chromatography |
| 02/05/2008 | US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2008 | US7326544 Reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs |
| 02/05/2008 | US7326543 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof |
| 02/05/2008 | US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis |
| 02/05/2008 | US7326536 Agents for treatment of HCV and methods of use |
| 02/05/2008 | US7326535 Using a for diagnosis, therapy |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326528 Method of detecting disease conditions in C. elegans infected with animal virus |
| 02/05/2008 | US7326419 Membrane proteins or polypeptides, used as vaccines or for medical diagnosis |
| 02/05/2008 | US7326418 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/05/2008 | US7326417 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 02/05/2008 | US7326416 Inhibition of HIV-1 virion production by a transdominant mutant of integrase interactor 1(INI1)/hSNF5 |
| 02/05/2008 | US7326415 derived from epithelial cells and malignant lymphoma; also for irritable bowel syndrome, viral and other infections; genetic engineering; kits |
| 02/05/2008 | US7326414 Monoclonal antibody that specifically binds macrophage colony stimulating factor; rheumatoid arthritis |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 02/05/2008 | US7326402 Method of diagnosing, monitoring, staging, imaging and treating cancer |
| 02/05/2008 | CA2283597C Reduced cortisol conjugates |
| 02/05/2008 | CA2255867C Chitosan induced immunopotentiation |
| 02/05/2008 | CA2124953C Peptides related to prion proteins |
| 01/31/2008 | WO2008014521A2 Improved vaccines and methods for using the same |
| 01/31/2008 | WO2008014484A1 Cellular receptor for antiproliferative factor |
| 01/31/2008 | WO2008014431A2 Method of treating ocular infections |
| 01/31/2008 | WO2008014386A2 Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists |
| 01/31/2008 | WO2008014035A2 Modulation of nkg2d and method for treating or preventing solid organ allograft rejection |
| 01/31/2008 | WO2008013954A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013948A2 Tyrosine phosphorylation sites |
| 01/31/2008 | WO2008013816A2 Tat-051 and methods of assessing and treating cancer |
| 01/31/2008 | WO2008013797A2 Compositions and methods for macular degeneration |
| 01/31/2008 | WO2008013552A2 Fully human hybridoma fusion partner cell lines |
| 01/31/2008 | WO2008013455A1 Means and methods for preventing elevated blood glucose levels in humans with animal antibodies produced in milk |
| 01/31/2008 | WO2008012538A2 Live vaccine strains of francisella |
| 01/31/2008 | WO2008012503A1 Homologue of pro4426 |
| 01/31/2008 | WO2008012062A1 Antigenic proteoliposomes and method of manufacture |
| 01/31/2008 | WO2008012049A1 Post-translationally modified neurotrophins |
| 01/31/2008 | WO2008012031A2 Blockers of gsk3 for the prevention and treatment of pemphigus vulgaris |
| 01/31/2008 | WO2008011711A1 Cancerous disease modifying antibodies |
| 01/31/2008 | WO2008011710A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 01/31/2008 | WO2008011709A1 Biomarkers for use in the diagnosis and treatment of colorectal cancer |
| 01/31/2008 | WO2008011672A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 01/31/2008 | WO2007137986A3 Vaccination against cancer |
| 01/31/2008 | WO2007120311A3 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 01/31/2008 | WO2007117356A3 Immunoglobulins from vitiligo plasma for melanoma therapy |
| 01/31/2008 | WO2007106224A3 Method of detecting or diagnosing of a neurodegenerative disease or condition |
| 01/31/2008 | WO2007095339A3 Methods of manufacturing corticosteroid solutions |
| 01/31/2008 | WO2007084499A8 Disease control in shrimp |
| 01/31/2008 | WO2007075808A3 Methods for preventing and/or treating a cell proliferative disorder |
| 01/31/2008 | WO2007067517A3 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants |
| 01/31/2008 | WO2007066226A3 Methods and compositions relating to adhesins as adjuvants |
| 01/31/2008 | WO2006113909A3 Humanized anti-cd70 binding agents and uses thereof |
| 01/31/2008 | WO2005118646A3 Epitope directed selection of antibodies to murine tissue factor |
| 01/31/2008 | WO2005056766A3 TARGETED DRUG DELIVERY USING EphA2 OR Eph4 BINDING MOIETIES |
| 01/31/2008 | US20080027214 Modulation of immunostimulatory activity of immunostimulatory Oligonucleotide analogs by positional chemical changes |
| 01/31/2008 | US20080027213 Chimeric immunogens |
| 01/31/2008 | US20080027147 polypeptides for use in the diagnosis and treatment of cell proliferative disorders |
| 01/31/2008 | US20080026449 Infectious Bronchitis Virus Vaccine |
| 01/31/2008 | US20080026402 Hematopoietin receptors HPR1 and HPR2 |
| 01/31/2008 | US20080026071 Microparticles for delivery of heterologous nucleic acids |
| 01/31/2008 | US20080026066 Liquids Containing Suspended Glass Particles |
| 01/31/2008 | US20080026065 Powdered Compositions Of Sensitive Active Materials In An At Least Partially Amorphous State |
| 01/31/2008 | US20080026047 Cancer Detection Reagents And Uses In Pathology And Diagnostics And Cancer Cell Death |
| 01/31/2008 | US20080026033 CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS |
| 01/31/2008 | US20080026012 Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex |
| 01/31/2008 | US20080026011 Immunostimulatory nucleic acid molecules |
| 01/31/2008 | US20080026010 Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination |
| 01/31/2008 | US20080026009 Borrelia burgdorferi bacterin |
| 01/31/2008 | US20080026008 Bacteriophage DNA vaccine vector |
| 01/31/2008 | US20080026007 Potentiation of the immune response |
| 01/31/2008 | US20080026006 Pharmaceutical composition useful for vaccines |
| 01/31/2008 | US20080026005 Multicopy-integration of heterologous genes and expression in methylobacterium |
| 01/31/2008 | US20080026004 Membrane virus host range mutations and their uses as vaccine substrates |
| 01/31/2008 | US20080026003 Methods for inhibiting pain |
| 01/31/2008 | US20080026002 Regimens for immunisation with meningococcal conjugates |
| 01/31/2008 | US20080026000 Nicotine hapten where nicotine in which the pyrrolidine ring is substituted by an omega-carboxy-, -amino-, -formyl- or -mercapto-alkyl group; useful in formulating vaccines for active immunization; preventing nicotine addiction |
| 01/31/2008 | US20080025999 Yersinia species compositions |
| 01/31/2008 | US20080025998 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chilamydia |
| 01/31/2008 | US20080025997 Cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| 01/31/2008 | US20080025996 Methods and Compositions Comprising Polycationic Compounds |
| 01/31/2008 | US20080025995 Cross-Placenta Delivery System |
| 01/31/2008 | US20080025994 Methods and compositions for the treatment of pancreatitis |
| 01/31/2008 | US20080025993 Method for Refolding Neisserial Nspa Protein |
| 01/31/2008 | US20080025992 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| 01/31/2008 | US20080025991 Use of Aromatase Inhibitors for Treatment of Ectopic Pregnancy |
| 01/31/2008 | US20080025990 anti-IGFR1 antibodies; combination with topoisomerase inhibitor such as irinotecanp; antitumor |
| 01/31/2008 | US20080025989 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 01/31/2008 | US20080025988 Monoclonal Antibody And Use Thereof |
| 01/31/2008 | US20080025987 Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix |
| 01/31/2008 | US20080025986 Methods of Treating Tnf-Mediated Disorders |
| 01/31/2008 | US20080025985 Method of treating a pathological syndrome and a pharmaceutical agent |